| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Evp/ Chief Scientific Officer | Chief Scientific Officer
1 company
Albright Charles is an Evp/ Chief Scientific Officer at Editas Medicine, Inc.. Recent SEC Form 4 filings include 0 buys and 13 sells.
Estimated insider holdings value: $84K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Dec 15, 2020 | EDIT Editas Medicine, Inc. | Evp/ Chief Scientific Officer | Sale+OE | 10,000 | $63.22 | $632,156.40 | -11.2% | |
| Dec 9, 2020 | EDIT Editas Medicine, Inc. | Evp/ Chief Scientific Officer | Sale+OE | 10,000 | $45.00 | $450,000.00 | -28.6% | |
| Dec 7, 2020 | EDIT Editas Medicine, Inc. | Evp/ Chief Scientific Officer | Sale+OE | 20,000 | $40.02 | $800,400.00 | -44.5% | |
| Nov 9, 2020 | EDIT Editas Medicine, Inc. | Evp/ Chief Scientific Officer | Sell | 228 | $31.21 | $7,115.88 | -0.9% | |
| Oct 15, 2020 | EDIT Editas Medicine, Inc. | Evp/ Chief Scientific Officer | Sell | 3,000 | $31.39 | $94,170.00 | -10.7% | |
| Aug 17, 2020 | EDIT Editas Medicine, Inc. | Evp/ Chief Scientific Officer | Sale+OE | 10,000 | $35.29 | $352,900.00 | -26.2% | |
| Aug 7, 2020 | EDIT Editas Medicine, Inc. | Evp/ Chief Scientific Officer | Sale+OE | 10,238 | $37.41 | $383,027.62 | -15.3% | |
| Jul 15, 2020 | EDIT Editas Medicine, Inc. | Evp/ Chief Scientific Officer | Sell | 3,000 | $32.22 | $96,660.00 | -9.6% | |
| May 6, 2020 | EDIT Editas Medicine, Inc. | Evp/ Chief Scientific Officer | Sell | 151 | $25.28 | $3,817.28 | -0.5% | |
| Feb 7, 2020 | EDIT Editas Medicine, Inc. | Chief Scientific Officer | Sell | 622 | $26.95 | $16,762.90 | -1.9% |